Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10551636rdf:typepubmed:Citationlld:pubmed
pubmed-article:10551636lifeskim:mentionsumls-concept:C0376387lld:lifeskim
pubmed-article:10551636lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:10551636lifeskim:mentionsumls-concept:C0919455lld:lifeskim
pubmed-article:10551636lifeskim:mentionsumls-concept:C0541315lld:lifeskim
pubmed-article:10551636lifeskim:mentionsumls-concept:C0920321lld:lifeskim
pubmed-article:10551636lifeskim:mentionsumls-concept:C0556643lld:lifeskim
pubmed-article:10551636lifeskim:mentionsumls-concept:C0750729lld:lifeskim
pubmed-article:10551636pubmed:issue8lld:pubmed
pubmed-article:10551636pubmed:dateCreated1999-11-16lld:pubmed
pubmed-article:10551636pubmed:abstractTextThis phase I, randomized, blinded, placebo-controlled study assessed the safety profile and pharmacokinetics of a 4-week course of once-daily, sequential ascending doses (0.75, 2.5, or 7.5 mg/day) of SDZ-RAD (RAD) capsules in renal transplant recipients on a stable regimen of cyclosporine (CsA; Neoral) and prednisone.lld:pubmed
pubmed-article:10551636pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10551636pubmed:languageenglld:pubmed
pubmed-article:10551636pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10551636pubmed:citationSubsetIMlld:pubmed
pubmed-article:10551636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10551636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10551636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10551636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10551636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10551636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10551636pubmed:statusMEDLINElld:pubmed
pubmed-article:10551636pubmed:monthOctlld:pubmed
pubmed-article:10551636pubmed:issn0041-1337lld:pubmed
pubmed-article:10551636pubmed:authorpubmed-author:KahanB DBDlld:pubmed
pubmed-article:10551636pubmed:authorpubmed-author:CarterCClld:pubmed
pubmed-article:10551636pubmed:authorpubmed-author:KatzS HSHlld:pubmed
pubmed-article:10551636pubmed:authorpubmed-author:Van BurenC...lld:pubmed
pubmed-article:10551636pubmed:authorpubmed-author:WongR LRLlld:pubmed
pubmed-article:10551636pubmed:authorpubmed-author:Appel-Dingema...lld:pubmed
pubmed-article:10551636pubmed:authorpubmed-author:Von...lld:pubmed
pubmed-article:10551636pubmed:issnTypePrintlld:pubmed
pubmed-article:10551636pubmed:day27lld:pubmed
pubmed-article:10551636pubmed:volume68lld:pubmed
pubmed-article:10551636pubmed:ownerNLMlld:pubmed
pubmed-article:10551636pubmed:authorsCompleteYlld:pubmed
pubmed-article:10551636pubmed:pagination1100-6lld:pubmed
pubmed-article:10551636pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:meshHeadingpubmed-meshheading:10551636...lld:pubmed
pubmed-article:10551636pubmed:year1999lld:pubmed
pubmed-article:10551636pubmed:articleTitleA phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients.lld:pubmed
pubmed-article:10551636pubmed:affiliationDepartment of Surgery, University of Texas Medical School, Houston 77030, USA.lld:pubmed
pubmed-article:10551636pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10551636pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10551636pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10551636pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10551636pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:10551636pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10551636lld:pubmed